SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-348894
Filing Date
2011-12-21
Accepted
2011-12-21 16:15:07
Documents
4
Period of Report
2012-02-16
Effectiveness Date
2011-12-21

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A DEFINITIVE PROXY STATEMENT d270568ddef14a.htm DEF 14A 502323
2 GRAPHIC g270568g07v87.jpg GRAPHIC 20144
3 GRAPHIC g270568g44u48.jpg GRAPHIC 7366
4 GRAPHIC g270568g84l26.jpg GRAPHIC 10566
  Complete submission text file 0001193125-11-348894.txt   556481
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-15803 | Film No.: 111274718
SIC: 2834 Pharmaceutical Preparations